Birdwatch Archive

Birdwatch Note Rating

2024-04-14 03:06:23 UTC - HELPFUL

Rated by Participant: 036E76E9D5E1CD110F64A1D7079C04BE4A8F6C8D732CCCFE41536EAFB7ACC007
Participant Details

Original Note:

É verdade que o medicamento Venvanse vai perder a patente em 2024. Porém o medicamento Juneve é apenas um semelhante, não pode ser considerado genérico, pois apesar da mesma composição não são utilizadas para os mesmos tratamentos https://site.cff.org.br/noticia/Noticias-gerais/15/03/2024/farmaceutica-deve-perder-patente-e-venvanse-pode-ganhar-versao-generica-e-mais-barata

All Note Details

Original Tweet

All Information

  • noteId - 1779335238990151845
  • participantId -
  • raterParticipantId - 036E76E9D5E1CD110F64A1D7079C04BE4A8F6C8D732CCCFE41536EAFB7ACC007
  • createdAtMillis - 1713063983125
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1779335238990151845036E76E9D5E1CD110F64A1D7079C04BE4A8F6C8D732CCCFE41536EAFB7ACC007